In the beginning of October the PanACEA Coordinator Martin Boeree travelled to Tanzania, Uganda and Gabon to continue the last site assessments of 2018, accompanied by lab coordinator Lavinia Rodney and project managers Lindsey te Brake and Rutger Spoor. We were happy to see the study teams of IHI, NIMR MMRC, KCRI (Tanzania), MML (Uganda)…
At the annual INTERTB meeting on October 22nd 2018 in London PanACEA Coordinator Martin Boeree and other renown experts on TB clinical drug development came together to discuss the research developments in the field. The 50 mg/kg rifampicin arm in the HR1 trial is completed and Martin Boeree lifted the veil on the preliminary results. We…
In the beautiful city of Lisbon, Portugal, the EDCTP held its Ninth Forum, an international platform for the presentation and discussion of frontier research to address the burden of poverty related infectious diseases in Sub-Saharan Africa. The theme of this Forum was the impact of European-African partnerships in clinical research, which is at the heart…
Every 3 months the PanACEA consortium is meeting via teleconference to update each other on the progress of the trials and the capacity development program. On September the 10th 2018 the partners assembled again. The so-called Expertise Cores can finally carry out their plans. They have started to purchase data management systems and statistical software. The PanACEA…
We are pleased to announce the opening of our Postgraduate programme, which will offer candidates a unique opportunity to support PanACEA objectives and obtain a research degree. The research programmes will be sponsored by expertise core and other affiliated resources. Candidates will be matched to appropriate projects based on their scientific interests, experience and acumen.…
Read more DEADLINE EXTENSION: Submission deadline 30 September for PanACEA Postgraduate Programme
The South African Medical Research Council interviewed Professor Andreas Diacon, founder and CEO at TASK Applied Science, on the future of TB treatment. TASK performs clinical trials in TB and has been a partner in the PanACEA consortium since the first EDCTP granting phase. New and improved drugs are necessary to increase the effectivity of treatment of TB, Professor…
Monday 11th June until Wednesday 13th June delegates from all over the world assembled for the MBLA Conference at the University of St Andrews, School of Medicine. The conference was organized and sponsored by the University of St Andrews and the Scottish Funding Council (SFC), in cooperation with the PanACEA Biomarkers Expertise Core. The conference…
From June 12-14th the EDCTP held a three-day competency training workshop in health research ethics, Good Clinical Practice and Good Clinical Laboratory Practice in Johannesburg, South Africa. The goal of the workshop was to improve the skills and capabilities of the participants to become a “Trainer-of-Trainers” or focal person within the research networks or regions…
As of June the PanACEA consortium welcomes Jean Marie Habarugira as the new EDCTP Project Officer. At the General Assembly meeting on June 11th the consortium had the first opportunity to get acquainted with him and an official visit will follow. Jean Marie Habarugira has been working for the EDCTP as Project Officer since 2010.…
Building up to this quarterly General Assembly (GA) meeting on June 11th the Expertise Cores developed a comprehensive trial capacity development proposal. The Cores are eager to start and the General Assembly gave the final go-ahead for their plans. PanACEA is one year into the project now and an Annual Report was submitted to its…
